Komori
Nippon Tungsten (6998) · InitiativeRestated

Accelerating Research and Development through Customer and Industry-Academia Collaboration

First written in FY2016. 15 of 23 entries say "Restated". Latest entry: FY2026-H1.

23entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2023-Q1 – FY2023-Q3AdvancedFY20242016: 120162017: 120172018: 420182019: 420192020: 420202021: 320212022: 320222023: 120232024: 120242025: 12025
Same theme, other companies
Customer Needs-Driven R&D through Collaboration with External Research Facilities and UniversitiesA theme 9 companies write about · 0 as a headwind · 9 as a tailwind

2 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「Total R&D expenses for the interim consolidated accounting period were ¥223 million.」

    The company continued its R&D activities and disclosed R&D expenses of ¥223 million for the interim consolidated accounting period.
  2. FY2024AdvancedAnnual report

    「Based on powder metallurgy technology, the Group continuously pursues advanced technologies, actively engages in joint research with government and academic institutions, and advances the development of innovative products.」

    The company continued developing innovative products through joint research with government and academic institutions, with R&D expenses for the fiscal year totaling ¥298 million.
  3. FY2023-Q3RestatedAnnual report

    「Total R&D expenses for the first 9 months of the fiscal year were ¥249 million.」

    The company continued its R&D activities and reported R&D expenses of ¥249 million for the first 9 months.
  4. FY2023-Q2RestatedAnnual report

    「Total R&D expenses for the first 6 months of the fiscal year were ¥172 million.」

    The company continued its R&D activities and reported R&D expenses of ¥172 million for the first 6 months.
  5. FY2023-Q1RestatedAnnual report

    「Total R&D expenses for the first 3 months of the fiscal year were ¥76 million.」

    The company continued its R&D activities and reported R&D expenses of ¥76 million for the first quarter.
  6. FY2022AdvancedAnnual report

    「Based on powder metallurgy technology, the Group continuously pursues advanced technologies, actively engages in joint research with government and academic institutions, and advances the development of innovative products.」

    The company continued developing products through joint research with government, academic and external research institutions, with R&D expenses for the fiscal year totaling ¥315 million.
  7. FY2022-Q2RestatedAnnual report

    「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year amounted to ¥139 million.」

    The company continued its R&D activities and reported R&D expenses of ¥139 million for the first 6 months.
  8. FY2021AdvancedAnnual report

    「Based on powder metallurgy technology, the Group continuously pursues advanced technologies, actively engages in joint research with government and academic institutions, and advances the development of innovative products.」

    The company continued joint research with government and academic institutions and advanced the development of innovative products. R&D expenses were reported at ¥269 million.
  9. FY2021-Q3RestatedAnnual report

    「Total R&D expenses for the first 9 months of the fiscal year were ¥198 million.」

    The company continued its R&D activities and reported total R&D expenses of ¥198 million for the first 9 months.
  10. FY2021-Q2RestatedAnnual report

    「Total R&D expenses for the first 6 months of the fiscal year were ¥135 million.」

    The company continued its R&D activities and reported R&D expenses of ¥135 million for the first 6 months.
  11. FY2021-Q1RestatedAnnual report

    「Total R&D expenses for the first 3 months of the fiscal year were ¥62 million.」

    The company continued its R&D activities and reported R&D expenses of ¥62 million for the first quarter.
  12. FY2020AdvancedAnnual report

    「In the Machinery Components Business, the company is focusing on developing products that meet customer and market needs, including research into applying its proprietary ceramics to components for semiconductor manufacturing equipment, and the development of highly durable components for secondary battery manufacturing and secondary battery manufacturing units. In the Electrical Components Business, the company is focusing on developing copper-tungsten contact electrodes used in electric vehicle relays, as well as R&D exploring new possibilities for a range of materials, not limited to tungsten. R&D expenses for the fiscal year were ¥262 million.」

    The company specified R&D themes including semiconductor manufacturing equipment, secondary batteries and contact electrodes for electric vehicles, with R&D expenses totaling ¥262 million.
  13. FY2020-Q3RestatedAnnual report

    「Total R&D expenses for the first 9 months of the fiscal year were ¥176 million.」

    The company reported R&D expenses of ¥176 million for the first 9 months and reaffirmed its continued R&D activities.
  14. FY2020-Q2RestatedAnnual report

    「Total R&D expenses for the six months ended the second quarter of the current consolidated fiscal year were ¥113 million.」

    The company disclosed R&D expenses of ¥113 million for the six months ended the second quarter and reaffirmed the continuation of its R&D activities.
  15. FY2020-Q1RestatedAnnual report

    「Total R&D expenses for the three months ended the first quarter of the current consolidated fiscal year were ¥55 million.」

    The company described the continuation of R&D activities and disclosed R&D expenses of ¥55 million for the three months ended the first quarter.
  16. FY2019AdvancedAnnual report

    「In the Machinery Components Business, we are focusing on developing products that meet customer and market needs, including research into applying proprietary ceramic materials to components for semiconductor manufacturing equipment, developing hard materials for wear-resistant components capable of withstanding harsh operating environments, and developing a high-efficiency machining support system using ultrafine bubbles for grinding and cutting. In the Electrical Components Business, we are pursuing R&D into new applications for tungsten, including tungsten components used in medical equipment and new tungsten alloys for plasma electrodes. R&D expenses for the current consolidated fiscal year were ¥223 million.」

    The company advanced research into ceramic applications, hard materials for wear-resistant components, ultrafine-bubble machining support, medical tungsten, and alloys for plasma electrodes, and recorded R&D expenses of ¥223 million.
  17. FY2019-Q3RestatedAnnual report

    「Total R&D expenses for the nine months ended the third quarter of the current consolidated fiscal year were ¥152 million.」

    The company disclosed R&D expenses of ¥152 million for the nine months ended the third quarter and reaffirmed the continuation of its R&D activities.
  18. FY2019-Q2RestatedAnnual report

    「Total R&D expenses for the six months ended the second quarter of the current consolidated fiscal year were ¥100 million.」

    The company described the continuation of R&D activities and disclosed total R&D expenses of ¥100 million for the six months ended the second quarter of the current consolidated fiscal year.
  19. FY2019-Q1RestatedAnnual report

    「Total R&D expenses for the three months ended the first quarter of the current consolidated fiscal year were ¥48 million.」

    The company described the continuation of R&D activities and disclosed R&D expenses of ¥48 million for the three months ended the first quarter of the current consolidated fiscal year.
  20. FY2018AdvancedAnnual report

    「In the Machinery Components Business, we are focusing on developing products that meet customer and market needs, including applied research on using proprietary ceramic materials in components for semiconductor manufacturing equipment and developing a machining support system using ultrafine bubbles for grinding and cutting. In the Electrical Components Business, we are pursuing research into new applications for tungsten, including tungsten components used in medical applications and electrodes for plasma generation. R&D expenses for the current consolidated fiscal year totaled ¥226 million.」

    The company advanced applied research on ceramic materials, a machining support system using ultrafine bubbles, medical tungsten components, and plasma electrodes, with R&D expenses totaling ¥226 million.
  21. FY2018-Q3RestatedAnnual report

    「Total R&D expenses for the nine months ended the third quarter of the current consolidated fiscal year were ¥157 million.」

    The company described the continuation of R&D activities and disclosed total R&D expenses of ¥157 million for the nine months ended the third quarter of the current consolidated fiscal year.
  22. FY2017AdvancedAnnual report

    「In the Machinery Components Business, we are focusing on developing products that meet customer and market needs, including applied research to commercialize newly developed proprietary ceramic materials in close collaboration with customers. In the Electrical Components Business, we are working to improve the performance of electrode materials such as resistance welding electrodes, deepen our powder metallurgy technologies, and actively conduct joint research with universities and companies. R&D expenses for the current consolidated fiscal year totaled ¥188 million.」

    The company detailed applied research into new ceramic materials, customer collaboration, improvements in electrode material performance, and joint research with universities and companies, and also disclosed R&D expenses.
  23. FY2016First statedAnnual report

    「By matching customer needs with our proprietary technologies, we develop products such as fine ceramics with unique functions. In addition, to accelerate research and development and shorten the time to commercialization, we actively conduct a broad range of joint research with companies, universities and other institutions, from basic research through applied product development. R&D expenses for this business totaled ¥193 million for the current consolidated fiscal year.」

    The company described matching customer needs with its technologies, joint research with companies and universities, and shortening commercialization timelines as means of advancing research and development.
Moved together

"Continuous Creation of New Technologies and Products" moved the same way as this thread, in the same document, in 6 of its 23 moves.

655444★123456
  1. ★This thread
  2. 1Continuous Creation of New Technologies and Products6×
  3. 2Introduction of a Restricted Stock Compensation Plan5×
  4. 3Strengthening Manufacturing Capabilities and Improving Production Efficiency5×
  5. 4Developing Talent to Support Technology4×
  6. 5Strengthening Internal Audit, Compliance and Internal Controls4×
  7. 6Deliberations by the Nomination and Compensation Advisory Committee4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Nippon Tungsten's next results are scheduled for 2026-11-11. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.